ATS Educational Products
2015
| B3 | COMMON CLINICAL DILEMMAS IN CONNECTIVE TISSUE DISEASE-ASSOCIATED ILD |
| B89 |
For more Best of ATS Conferences materials visit the following link https://store.thoracic.org or please contact Barbara Horner at bhorner@thoracic.org
-
Free CME/CNE Credits
-
- The Scleroderma Foundation proudly announced its first ever free CME program for doctors and nurses earlier this year. Credits are available online. More credits will be offered in person in select cities. Check back for more updates.
-
Research Grant Program
-
- The Scleroderma Foundation is a leading nonprofit supporter of scleroderma research.The Foundation budgets an average of $1 million each year to find the cause and cure of scleroderma.
-
Scleroderma Foundation Multi-Center Collaborative Grant
-
- The Scleroderma Foundation’s newest research initiative involves multi-center research funding. It is an exciting opportunity for our research and treatment centers to work together to try and discover a cure. Find more information here.
-
Scleroderma Foundation Physician Books
-
- The Scleroderma Foundation keeps a list of books that can be helpful to physicians. The list is available here:www.scleroderma.org/physicianbooks
ATS Journal articles on Scleroderma
AJRCCM
Hemodynamic Predictors of Survival in Scleroderma-related Pulmonary Arterial Hypertension
Volume: 182, Issue: 2 (July 15, 2010)
Read Abstract
Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma
Volume: 179, Issue: 5 (March 1, 2009)
Read Abstract
Borderline Pulmonary Arterial Pressure Is Associated with Decreased Exercise Capacity in Scleroderma
Volume: 180, Issue: 9 (November 1, 2009)
Read Abstract
Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease
Volume: 177, Issue: 1 (January 1, 2008)
Read Abstract
Volume: 176, Issue: 10 (November 15, 2007)
Read Abstract
Partitioning of Alveolar and Conducting Airway Nitric Oxide in Scleroderma Lung Disease
Volume: 165, Issue: 12 (June 15, 2002)
Read Abstract
Mast Cells' Contribution to the Fibrosing Alveolitis of the Scleroderma Lung
Volume: 147, Issue: 6_pt_1 (June, 1993)
Read Abstract
AJRCMB
Resistin-Like Molecule-β in Scleroderma-Associated Pulmonary Hypertension
Volume: 41, Issue: 5 (November, 2009)
Read Abstract
Curcumin-Induced Apoptosis in Scleroderma Lung Fibroblasts: Role of Protein Kinase Cε
Volume: 31, Issue: 1 (July, 2004)
Read Abstract
Gene Expression in Bronchoalveolar Lavage Cells from Scleroderma Patients
Volume: 26, Issue: 5 (May, 2002)
Read Abstract
Fibronectin Gene Polymorphisms Associated with Fibrosing Alveolitis in Systemic Sclerosis
Volume: 20, Issue: 1 (January, 1999)
Read Abstract
Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor.
Volume: 10, Issue: 4 (April, 1994)
Read Abstract
AnnalsATS
State of the Art. Mechanisms of Scleroderma-induced Lung Disease
Volume: 4, Issue: 5 (August, 2007)
Read Abstract
ATS Statements, Guidelines and Reports
ATS Statements, Guidelines and Reports are printed in the American Journal of Respiratory and Critical Care Medicine. These documents are also available in PDF format. You may download one copy of any ATS document; there is no charge for this service. Some examples below:
- The Association between Health Insurance Status and Access, Care Delivery, and Outcomes for Critically Ill Patients (2010)
- Pay-for-Performance in Pulmonary, Critical Care, and Sleep Medicine (2010)
- An Official ATS Policy Statement: Managing Conflict of Interest in Professional Societies (2009)
- An Official ATS Statement: Grading the Quality of Evidence and Strength of Recommendations in ATS Guidelines and Recommendations (2006)
